Gene · 4172
Papers2,183
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,183
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis. | Leuk Res | 2025 | 40591982 | PubTator, text mining | PubMed |
| Overexpression of LINC00880 promotes colorectal cancer growth. | Transl Cancer Res | 2025 | 40530165 | PubTator, text mining | PubMed |
| Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs. | Cancer Lett | 2025 | 40482911 | PubTator, text mining | PubMed |
| Enhancing hepatocellular carcinoma treatment: synergistic cytotoxicity and mechanistic insights of Ramucirumab and 5-Azacytidine combination therapy. | Saudi Pharm J | 2025 | 40397219 | PubTator, text mining | PubMed |
| Transcriptomic Profiling Highlights Metabolic and Biosynthetic Pathways Involved in In Vitro Flowering in Anoectochilus roxburghii (Wall.) Lindl. | Genes (Basel) | 2025 | 40004461 | PubTator, text mining | PubMed |
| Overexpression of MCM3 as a prognostic biomarker correlated with cell proliferation, cell cycle and immune regulation in hepatocellular carcinoma. | J Cancer | 2025 | 39991578 | PubTator, text mining | PubMed |
| MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathway. | Ann Hepatol | 2025 | 39978465 | PubTator, text mining | PubMed |
| The EZH2/MCM Complex/hTERT axis facilitates hepatocellular carcinoma progression by inhibiting cellular senescence. | Mech Ageing Dev | 2025 | 39933657 | PubTator, text mining | PubMed |
| Sequence specificity of an essential nuclear localization sequence in Mcm3. | PLoS Genet | 2025 | 39836669 | PubTator, text mining | PubMed |
| Precisely Designed Hydrophilic Networks in Microporous Layer for High Performance of Proton Exchange Membrane Fuel Cells. | ACS Appl Mater Interfaces | 2025 | 39832886 | PubTator, text mining | PubMed |
| RNA Sequencing and Weighted Gene Co-Expression Network Analysis Highlight DNA Replication and Key Genes in Nucleolin-Depleted Hepatoblastoma Cells. | Genes (Basel) | 2024 | 39766782 | PubTator, text mining | PubMed |
| Knockdown of ribosomal protein L22-like 1 arrests the cell cycle and promotes apoptosis in colorectal cancer. | Cytojournal | 2024 | 39737125 | PubTator, text mining | PubMed |
| CrossIsoFun: predicting isoform functions using the integration of multi-omics data. | Bioinformatics | 2024 | 39680906 | PubTator, text mining | PubMed |
| Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers. | J Alzheimers Dis | 2024 | 39604273 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma. | Front Immunol | 2024 | 39324133 | PubTator, text mining | PubMed |
Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry. | Ann Med | 2024 | 39310930 | PubTator, text mining | PubMed |
| A Study of Small Intestinal Epigenomic Changes Induced by Royal Jelly. | Cells | 2024 | 39272991 | PubTator, text mining | PubMed |
| The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort. | Front Pharmacol | 2024 | 38698811 | PubTator, text mining | PubMed |
| Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis. | BMC Cancer | 2024 | 38693472 | PubTator, text mining | PubMed |
| The MCM2-7 Complex: Roles beyond DNA Unwinding. | Biology (Basel) | 2024 | 38666870 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4172/papers?page=3